Skip to content

Effect and effect mechanisms of neuromagnetic treatment for pain of knee osteoarthritis

Effect and effect mechanisms of neuromagnetic treatment for pain of knee osteoarthritis

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000395235
Acronym
QMOAK Trial
Enrollment
10
Registered
2009-06-02
Start date
2009-04-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Effect and effect mechanism of neuromagnetic treatment for pain of knee osteoarthritis. Application of neuromagnetic devices for decreasing pain and increasing function of participants suffering from mild to moderate osteoarthritis of the knee.

Interventions

Quadrapolar Neuromagnetic device, Magnetic Flux Generator(MFG), (Qmagnets tm) These consist of 4 centre charged 12 500 gauss magnets with alternating polarities that produce steep field gradients that are purported to have physiological effects. Active magnets will be applied to particpants for a one week period with a one week period wash out and one week period of wearing a placebo device. The participants will be computerized random coding system. The researcher will be blinded to activ

Quadrapolar Neuromagnetic device, Magnetic Flux Generator(MFG), (Qmagnets tm) These consist of 4 centre charged 12 500 gauss magnets with alternating polarities that produce steep field gradients that are purported to have physiological effects. Active magnets will be applied to particpants for a one week period with a one week period wash out and one week period of wearing a placebo device. The participants will be computerized random coding system. The researcher will be blinded to active and passive device intervention.

Sponsors

Qmagnets
Lead SponsorCommercial sector/Industry

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

Mild to moderate knee osteoarthritis

Exclusion criteria

Severe deforming arthritis, concommitant health conditions that would effect trial results.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026